IDEXX Laboratories Inc (IDXX)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 61.08% | 60.76% | 60.45% | 60.14% | 59.82% | 59.89% | 59.97% | 59.71% | 59.52% | 59.16% | 58.70% | 58.56% | 58.76% | 58.77% | 58.83% | 58.86% | 58.04% | 57.61% | 57.18% | 56.71% |
| Operating profit margin | 28.99% | 28.97% | 28.67% | 29.95% | 29.97% | 30.06% | 29.82% | 27.13% | 26.69% | 26.09% | 25.77% | 28.49% | 28.99% | 29.28% | 28.35% | 27.92% | 25.66% | 24.12% | 23.96% | 22.95% |
| Pretax margin | 28.48% | 28.43% | 28.06% | 29.24% | 28.99% | 28.84% | 28.49% | 25.83% | 25.54% | 25.11% | 24.89% | 27.61% | 28.07% | 28.33% | 27.35% | 26.78% | 24.46% | 22.89% | 22.71% | 21.74% |
| Net profit margin | 22.78% | 22.53% | 22.34% | 23.26% | 23.08% | 22.93% | 22.52% | 20.38% | 20.17% | 20.05% | 20.07% | 22.43% | 23.17% | 24.14% | 23.89% | 23.59% | 21.49% | 19.20% | 18.59% | 17.78% |
IDEXX Laboratories Inc has shown a consistently increasing trend in its profitability ratios over the past few years.
1. Gross Profit Margin: The company's gross profit margin has improved steadily from 56.71% as of March 31, 2020, to 61.08% as of December 31, 2024. This indicates that IDEXX has been effectively managing its production costs and generating more profits from its core operations.
2. Operating Profit Margin: IDEXX has demonstrated an upward trend in its operating profit margin, reaching 29.95% as of March 31, 2024, from 22.95% as of March 31, 2020. This shows that the company has been efficient in controlling its operating expenses while increasing its operating income.
3. Pretax Margin: The pretax margin has also seen a consistent improvement, moving from 21.74% as of March 31, 2020, to 29.24% as of March 31, 2024. This signifies that IDEXX has been effective in managing its pre-tax profitability and generating higher earnings before taxes.
4. Net Profit Margin: The net profit margin has increased from 17.78% as of March 31, 2020, to 22.78% as of December 31, 2024. This shows that IDEXX has been successful in controlling its overall expenses, including taxes, interest, and other costs, to increase its net income relative to its revenue.
Overall, the profitability ratios of IDEXX Laboratories Inc reflect a positive trend, indicating the company's ability to efficiently convert revenues into profits over the analyzed period.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 34.31% | 33.24% | 31.77% | 33.27% | 33.66% | 34.94% | 36.50% | 33.14% | 32.72% | 33.01% | 32.70% | 35.98% | 38.24% | 38.48% | 35.81% | 34.28% | 30.27% | 30.53% | 30.24% | 29.90% |
| Return on assets (ROA) | 26.96% | 25.85% | 24.76% | 25.84% | 25.92% | 26.66% | 27.57% | 24.90% | 24.72% | 25.36% | 25.47% | 28.33% | 30.56% | 31.72% | 30.17% | 28.97% | 25.35% | 24.30% | 23.47% | 23.16% |
| Return on total capital | 71.77% | 69.72% | 69.43% | 71.78% | 74.26% | 83.45% | 96.15% | 111.08% | 148.28% | 183.87% | 187.33% | 146.31% | 135.55% | 122.05% | 116.01% | 114.01% | 110.41% | 142.66% | 218.44% | 526.74% |
| Return on equity (ROE) | 55.65% | 53.54% | 53.51% | 55.23% | 56.92% | 63.41% | 72.35% | 83.13% | 111.56% | 140.68% | 145.28% | 114.81% | 107.95% | 100.28% | 97.38% | 95.95% | 92.04% | 112.92% | 168.56% | 405.73% |
IDEXX Laboratories Inc has shown consistently strong profitability ratios over the past few years.
1. Operating return on assets (Operating ROA) has been trending upwards, reaching a peak of 38.48% as of September 30, 2021, before slightly decreasing to 33.24% as of September 30, 2024. This indicates that the company generates a significant operating profit relative to its total assets.
2. Return on assets (ROA) has also exhibited a positive trend, with values ranging from 23.16% on March 31, 2020, to 26.96% on December 31, 2024. This ratio illustrates the company's ability to generate profits from its assets.
3. Return on total capital has been volatile, with a significant increase from 526.74% on March 31, 2020, to 187.33% on June 30, 2022, before declining to 71.77% on December 31, 2024. Despite the fluctuations, the company has maintained relatively high returns on its total capital.
4. Return on equity (ROE) has followed a similar pattern, starting at 405.73% on March 31, 2020, and gradually decreasing to 55.65% on December 31, 2024. This indicates that shareholders have been receiving impressive returns relative to their equity investments.
Overall, the profitability ratios suggest that IDEXX Laboratories Inc has been effectively utilizing its assets and capital to generate profits for both the company and its shareholders.